Index:
Overview
Results: Pricing, Volume, Margins and Recoveries
Generic Commentary
Where Everyone Is Winning
Biologicals and Plant Health
Restructuring Dynamics
Seed: Corn, Soybean, and the Race to Hybrid Wheat
1. Overview
After three of the more turbulent years the crop protection industry has seen, executives of six of the largest crop protection and seed companies are using the similar phrases to describe where the market is at.
The market has not boomed, but it has begun to stabilize, and 2026 is the first year most of them are pointing to volume growth and margin recovery, with results that reinforce this.
Mike Frank, CEO of UPL Corp captured the long arc well in his comments at the UPL Capital Markets Day. He shared that:
“Even though the market hasn't rebounded, I would say it's recovered and it's stabilized. But we found many opportunities to introduce new technologies to serve our farmer customers and to disproportionately grow in a very challenging market. We now assume market volatility is the norm.”
That last sentence effectively frames every Q1 2026 commentary in this overview.
Volatility is expected and it is now built into the assumptions.
ADAMA framed the macro most neutrally stating that demand has come back, channel inventories have normalized, but pricing remains under structural pressure and farmer profitability is the variable that is important to watch. As ADAMA put it in its Q1 2026 release:
“In the first quarter of 2026 pricing pressures remain elevated due to persistent oversupply and production over-capacity of active ingredients. Crop commodity prices are stabilizing at relatively low levels but remain sensitive to geopolitical risks, limiting upside for farmer income. As a result, ongoing pressure on farmer profitability continues to drive just-in-time purchasing behavior, even as volumes normalize across most markets.”
That was echoed by Bayer, FMC, BASF, and Corteva on their calls.
2. Pricing, Volume, and Margins
Between all of the major players, the results still varied a bit.
Bayer and Corteva delivered EBITDA growth on the back of seed strength and one-time licensing items — though, crop protection was a challenge for Bayer.
Syngenta, ADAMA, and UPL drove volume-led top-line growth and either expanded or held margin.
FMC is calling 2026 a trough year, with recovering expected in 2027.
Bayer Crop Science put up notable numbers. As CFO Wolfgang Nickl said:
Subscribe to Upstream Ag Professional to read the rest.
Become a paying member of Upstream Ag to get access to this post and other subscriber-only content.
UpgradeA Professional Membership Delivers:
- Subscriber-only insights and deep analysis plus full archive access
- Audio edition for consumption flexibility
- AskUpstream Access, the LLM for serious agribusiness professionals
- Access to the Report Hub and Visualization Hub
